ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 463

$2.04M Total Retail Price of All Prescriptions

Rank: 3 out of 463

707 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

9% of this provider’s 20,002 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $131 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 1,222 859 1 1
JANUVIA 1,116 919 10 2 6
GLYBURIDE-METFORMIN HCL 1,051 855 R 10 3 38
CRESTOR 939 748 4 13
GABAPENTIN 845 684 5 48
SIMVASTATIN 736 585 6 7
ACTOS 668 534 10 7 24
GLYBURIDE MICRONIZED 659 499 R 10 8 92
DIOVAN HCT 630 539 9 59
OMEPRAZOLE 591 433 10 27
AMLODIPINE BESYLATE 535 490 11 12
AMLODIPINE BESYLATE-BENAZEPRIL 533 460 12 81
DICLOFENAC SODIUM 504 397 13 104
FUROSEMIDE 484 439 14 25
NEXIUM 454 361 15 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 447 325 16 77
LANTUS 421 325 17 16
ZETIA 388 328 18 33
LANTUS SOLOSTAR 374 243 19 4
MICARDIS HCT 329 296 10 20 127
JANUMET 328 238 21 17
METOPROLOL SUCCINATE 320 284 22 28
METFORMIN HCL 297 176 23 3
PIOGLITAZONE HCL 284 239 R 10 24 68
ALENDRONATE SODIUM 271 258 25 22
ACTOPLUS MET 266 223 10 26 93
ATORVASTATIN CALCIUM 259 200 27 10
LISINOPRIL 252 213 28 15
LABETALOL HCL 229 152 29 118
ALCOHOL SWABS 225 189 30 57
CARVEDILOL 219 181 31 47
SINGULAIR 212 165 32 84
MECLIZINE HCL 202 170 33 128
AMMONIUM LACTATE 201 160 34 87
LOSARTAN-HYDROCHLOROTHIAZIDE 188 172 35 51
INSULIN SYRINGE 185 171 36 18
MELOXICAM 172 145 37 136
METOPROLOL TARTRATE 171 157 38 31
DIOVAN 167 119 39 42
SINGLE USE SWAB 166 125 40 58
NIFEDIPINE ER 163 143 41 72
CLOPIDOGREL 158 149 42 64
VYTORIN 155 139 43 83
PLAVIX 155 121 43 61
HYDROCHLOROTHIAZIDE 150 113 45 26
GLIPIZIDE 149 121 46 36
IBUPROFEN 144 86 47 125
LOVAZA 143 86 48 39
ALCOHOL PREP PADS 137 104 49 108
VENTOLIN HFA 137 90 49 119
MONTELUKAST SODIUM 134 108 51 140
METHIMAZOLE 133 104 52 21
TAMSULOSIN HCL 126 124 53 67
ATENOLOL 123 95 54 29
PIOGLITAZONE-METFORMIN 119 92 R 10 55 189
VALSARTAN-HYDROCHLOROTHIAZIDE 118 98 56 191
EXFORGE 116 78 57 101
AMITRIPTYLINE HCL 112 59 R 58 196
CLONIDINE HCL 109 95 59 131
PRAZOSIN HCL 108 88 60 204
FENOFIBRATE 101 101 61 71
NAPROXEN 94 72 62 165
LANSOPRAZOLE 89 76 63 181
METOCLOPRAMIDE HCL 85 76 64 174
PRAVASTATIN SODIUM 84 74 65 43
SURE COMFORT ALCOHOL 83 49 66 216
ADVAIR DISKUS 83 68 66 96
SYNTHROID 77 36 68 2
ENALAPRIL MALEATE 75 37 69 35
ISOSORBIDE MONONITRATE ER 73 73 70 105
RANITIDINE HCL 72 41 71 107
GLIPIZIDE XL 69 57 72 46
FLUTICASONE PROPIONATE 66 46 73 129
MICARDIS 63 57 74 141
UNIFINE PENTIPS 61 31 75 54
CLOTRIMAZOLE-BETAMETHASONE 60 51 76 157
LEVOXYL 59 36 77 23
CALCITRIOL 59 42 77 86
DONEPEZIL HCL 59 59 77 79
ZOLPIDEM TARTRATE 57 42 80 44
GLYBURIDE 57 55 R 80 41
EVISTA 57 50 80 65
TRAMADOL HCL 57 19 80 85
AMITIZA 56 56 84 250
DOXAZOSIN MESYLATE 56 54 84 174
BENAZEPRIL HCL 55 55 86 163
VOLTAREN 54 49 87 144
LIPITOR 54 45 87 60
HUMALOG 54 42 87 14
MONOJECT INSULIN SYRINGE 53 47 90 206
PROPRANOLOL HCL 53 46 90 259
SURE COMFORT 51 22 92 263
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.